Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study.
Bertsias A, Avgoustidis N, Papalopoulos I, Repa A, Kougkas N, Kalogiannaki E, Bertsias G, Flouri I, Sidiropoulos P. Bertsias A, et al. Among authors: avgoustidis n. Arthritis Res Ther. 2022 Jun 2;24(1):132. doi: 10.1186/s13075-022-02826-6. Arthritis Res Ther. 2022. PMID: 35655317 Free PMC article.
In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study.
Fanouriakis A, Papalopoulos I, Gergianaki I, Spyrou G, Erden A, Rapsomaniki P, Terizaki M, Avgoustidis N, Repa A, Kougkas N, Bertsias G, Boumpas DT, Sidiropoulos PI. Fanouriakis A, et al. Among authors: avgoustidis n. Clin Exp Rheumatol. 2018 Sep-Oct;36(5):806-813. Epub 2018 Feb 28. Clin Exp Rheumatol. 2018. PMID: 29533750
Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus.
Adamichou C, Nikolopoulos D, Papastefanakis E, Kalogiannaki E, Gergianaki I, Kountouri A, Repa A, Avgoustidis N, Kougkas N, Sidiropoulos P, Fanouriakis A, Bertsias G. Adamichou C, et al. Among authors: avgoustidis n. Mediterr J Rheumatol. 2018 Dec 18;29(4):232-235. doi: 10.31138/mjr.29.4.232. eCollection 2018 Dec. Mediterr J Rheumatol. 2018. PMID: 32185334 Free PMC article.
The value of the 2011 ASAS classification criteria in patients with Spondyloarthritis and the prognosis of non-radiographic axial Spondyloarthritis: data from a large cohort of a tertiary referral hospital.
Kougkas N, Avgoustidis N, Repa A, Bertsias G, Eskitzis A, Sidiropoulos P. Kougkas N, et al. Among authors: avgoustidis n. Mediterr J Rheumatol. 2019 Mar 28;30(1):51-53. doi: 10.31138/mjr.30.1.51. eCollection 2019 Mar. Mediterr J Rheumatol. 2019. PMID: 32185344 Free PMC article.
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI).
Piga M, Floris A, Espinosa G, Serpa Pinto L, Kougkas N, Lo Monaco A, Lopalco G, Orlando I, Pirani V, Santos E, Bertsias G, Cantarini L, Cauli A, Cervera R, Correia J, Govoni M, Iannone F, Neri P, Martins Silva A, Vasconcelos C, Muntoni M, Mathieu A; the BODI Project Group. Piga M, et al. RMD Open. 2020 Jul;6(2):e001192. doi: 10.1136/rmdopen-2020-001192. RMD Open. 2020. PMID: 32703843 Free PMC article.
Successful treatment of Cogan's syndrome with tocilizumab.
Kougkas N, Bertsias G, Stratoudaki R, Avgoustidis N. Kougkas N, et al. Among authors: avgoustidis n. Scand J Rheumatol. 2021 Jul;50(4):330-331. doi: 10.1080/03009742.2020.1818822. Epub 2020 Oct 13. Scand J Rheumatol. 2021. PMID: 33047628 No abstract available.
23 results